News

News 05.11.2024 Zurich, Switzerland – November 4, 2024 InSphero, the pioneer in 3D cell culture and organ-on-chip technologies, today announced its distribution partnership with Chayon, a leading Seoul-based laboratory supplies provider. This partnership will bring InSphero’s reliable and scalable 3D in vitro solutions for drug development to South Korean researchers, further expanding the company’s global...

Events, Internal events
Event date: 21.11.2024 Date and Time: November 21st, 9:30 – 10:30 am Location: Auditorium at Wagistrasse 25, Bio-Technopark   Join us on November 21st at our upcoming seminar series as Genewiz commemorates the 5-year anniversary of our Leipzig laboratory! Enjoy complimentary refreshments while you attend our seminar and network with our local Genewiz team and discover...

Events, Internal events
Event date: 03.12.2024 Join our event on Tuesday, 03 December 2024 at 12 pm in the Auditorium  (Bio-Technopark, Wagistrasse 25, Schlieren) Depending on your innovation, whether it is a product such as a drug, cosmetic, or food product, a manufacturing process, or a screening method, different aspects need to be considered when it comes...

News 04.11.2024 Schlieren / Zurich, Switzerland, 4 November, 2024 – Memo Therapeutics AG (or “MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer, announces today that Frits van Alphen, MD has been appointed as Chief Development Officer (CDO). He succeeds Dr. Gerald P. Parzmair, who stepped...

News 01.11.2024 Schlieren / Zurich, Switzerland, 1 November, 2024 – Memo Therapeutics AG (or “MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer, announces today that the last patient has been enrolled in its 22-site U.S. Phase II trial for its BK polyomavirus (“BKV”)-neutralizing antibody, potravitug. With...